This year’s ANZCCP delivered some strong themes that resonated closely with where we are as a business.
The clearest signal across the event was a shift towards precision over volume, a move away from broad, high-volume activity towards more targeted, quality-led engagement.
There was also a strong appetite across the sector for deeper collaboration between suppliers, prescribers and pharmacy, with patient outcomes at the centre. Vertical integration was a consistent focus in these conversations.
On regulation and access, there was plenty of forward momentum and practical discussion about what the next 12 months look like, including potential limits for THC potency, with recognition that differences exist depending on dosage form.
Our Australian team summed it up well:
“ANZCAPP was a fantastic few days, the calibre of discussion reflected just how quickly our industry is maturing but also under huge reform in Australia. The standout theme for me was precision over volume: a real shift towards quality, targeted engagement & genuine patient outcomes. Exciting times ahead as we continue to progress the regulatory pathway for QMID in Australia”
